Prolonged stabilization of platinum-resistant ovarian cancer in a single patient consuming a fermented soy therapy

Gynecologic Oncology

Volumn 100, Issue 1, 2006, Pages 205-209

  Klein, Amber ^a   He, Xiaoying ^a   Roche, Maria ^a   Mallett, Allison ^a   Duska, Linda ^a   Supko, Jeffrey G ^a   Seiden, Michael V ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Alternative therapies; Genistein; Ovarian cancer; Platinum resistance

Indexed keywords

CA 125 ANTIGEN; FLUDROXYCORTIDE; GENISTEIN; HAELAN 951; ISOFLAVONE; PLATINUM;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CASE REPORT; CONCENTRATION (PARAMETERS); DISEASE COURSE; FEMALE; FERMENTED PRODUCT; HUMAN; OVARY CANCER; PRIORITY JOURNAL; SOYBEAN;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; COMPLEMENTARY THERAPIES; DEOXYCYTIDINE; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENISTEIN; GLUCURONIDES; HUMANS; ISOFLAVONES; MIDDLE AGED; OVARIAN NEOPLASMS; PACLITAXEL; SOY MILK; TOPOTECAN;

EID: 29144489524     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.08.006     Document Type: Article

References (24)

1. R.F. Ozols, B.N. Bundy, B.E. Greer, J.M. Fowler, D. Clarke-Pearson, and R.A. Burger Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study J Clin Oncol 21 17 2003 3194 3200
2. M. Markman, K. Webster, K. Zanotti, G. Peterson, B. Kulp, and J. Belinson Survival following the documentation of platinum and taxane resistance in ovarian cancer: a single institution experience involving multiple phase 2 clinical trials Gynecol Oncol 93 3 2004 699 701
3. A.N. Gordon, J.T. Fleagle, D. Guthrie, D.E. Parkin, M.E. Gore, and A.J. Lacave Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan J Clin Oncol 19 14 2001 3312 3322
4. R.T. Penson, C.M. Castro, M.V. Seiden, B.A. Chabner, and T.J. Lynch Jr. Complementary, alternative, integrative or unconventional medicine? Oncologist 6 5 2001 463 473
5. H. Kappauf, D. Leykauf-Ammon, U. Bruntsch, M. Horneber, G. Kaiser, and G. Buschel Use of and attitudes held towards unconventional medicine by patients in a department of internal medicine/oncology and haematology Support Care Cancer 8 4 2000 314 322
6. A.A. Franke, L.J. Custer, L.R. Wilkens, L.L. Mrachand, A.M.Y. Nomure, and M.T. Goodman Liquid chromatographic-photodiode array mass spectrometric analysis of dietary phytoestrogens from human urine and blood J Chromatogr, B 777 2002 45 59
7. J. Liggins, L.J.C. Bluck, W.A. Coward, and S.A. Bingham Extraction and quantification of daidzein and genistein in food Anal Biochem 264 1998 1 7
8. Y. Zhang, S. Hendrich, and P.A. Murphy Glucuronides are the main isoflavone metabolites in women J Nutr 133 2003 399 404
9. H. Kim, T.G. Peterson, and S. Barnes Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor beta signaling pathways Am J Clin Nutr 68 6 Suppl 1998 1418S 1425S
10. P.L. Horn-Ross, S. Barnes, M. Lee, L. Coward, J.E. Mandel, and J. Koo Assessing phytoestrogen exposure in epidemiologic studies: development of a database (United States) Cancer Causes Control 11 2000 289 298
11. R.A. King, J.L. Broadbent, and R.J. Head Absorption and excretion of the soy isoflavone genistein in rats J Nutr 126 1 1996 176 182
12. S. Hendrich Bioavailability of isoflavones J Chromatogr, B 777 2002 203 210
13. H. Adlercreutz, T. Fotsis, J. Lampe, K. Wahala, T. Makela, and G. Brunow Quantitative determination of lignans and isoflavonoids in plasma of omnivorous and vegetarian women by isotope dilution gas chromatography-mass spectrometry Scand J Lab Invest 53 1993 5 18
14. S. Staar, D.U. Richter, J. Makovitsky, V. Briese, and C. Bergemann Stimulation of endometrial glandular cells with genistein and daidzein and their effects on ERalpha- and ERbeta-mRNA and protein expression Anti Cancer Res 25 3A 2005 1713 1718
15. Y. Li, K.L. Ellis, S. Ali, B.F. El-Rayes, A. Nedeljkovic-Kurepa, and O. Kucuk Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-kappaB in BxPC-3 pancreatic cancer cell line Pancreas 28 4 2004 90 95
16. X. Huang, S. Chen, L. Xu, Y. Liu, D.K. Deb, and L.C. Platanias Genistein inhibits p38 MAP kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells Cancer Res 65 2005 3470 3478
17. A.I. Constantinou, B.E. White, D. Tonetti, Y. Yang, W. Lian, and W. Li The soy isoflavone daidzein improves the capacity of tamoxifen to prevent mammary tumours Eur J Cancer 41 2005 647 654
18. X. Chen, and J.J. Anderson Isoflavones inhibit proliferation of ovarian cancer cells in vitro via an estrogen receptor-dependent pathway Nutr Cancer 41 1-2 2001 165 171
19. C. Gercel-Taylor, A.K. Feitelson, and D.D. Taylor Inhibitory effect of genistein and daidzein on ovarian cancer cell growth Anticancer Res 24 2B 2004 795 800
20. R.A. Jarred, M. Keikha, C. Dowling, S.J. McPherson, A.M. Clare, and A.J. Husband Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones Cancer Epidemiol Biomark Prev 11 12 2002 1689 1696
21. R.R. Newbold, E.P. Banks, B. Bullock, and W.N. Jefferson Uterine adenocarcinoma in mice treated neonatally with genistein Cancer Res 61 2001 4325 4328
22. J.E. Thigpen, J. Locklear, J.K. Haseman, H. Saunders, M.F. Grant, and D.B. Forsythe Effects of the dietary phytoestrogens daidzein and genistein on the incidence of vulvar carcinomas in 129/J mice Cancer Detec Prev 25 2001 527 532
23. C.D. Allred, K.F. Allred, Y.H. Ju, S.M. Virant, and W.G. Helfrerich Soy diets containing varying amounts of genistein stimulated growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner Cancer Res 61 2001 5045 5050
24. C.V. Rao, C.X. Wang, B. Simi, R. Lubet, G. Kelloff, and V. Steele Enhancement of experimental colon cancer by genistein Cancer Res 57 1997 3717 3722